Option chain shows key data for Yubico's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Yubico.

Yubico (OTC:YUBCF) Stock, Option Chain

Yubico AB is a leader in setting global standards for secure access to computers, mobile devices, servers, browsers, and internet accounts. Yubico is a creator and core contributor to the FIDO2, WebAuthn, and FIDO Universal 2nd Factor (U2F) open authentication standards, and is a pioneer in delivering modern, hardware-based passkey authentication security at scale to customers in over 160 countries. The company is a global cybersecurity company and inventor of the YubiKey, which offers the gold standard for phishing-resistant multi-factor authentication (MFA).

Yubico AB

Macro Economic Events

News

Politics

Economics

General

Acting Director Of U.S. Consumer Financial Protection Bureau Instructs All Staff Not To Perform 'Any Work Task,' Email Says

CSP (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSPI#NASDAQ">CSPI</a>) reported quarterly earnings of $0.05 per share. This is a 350 percent increase over losses of $(0.02) per share from the same period last year. The company reported $15.67 million in sales this quarter. This is a 1.92 percent increase over sales of $15.38 million the same period last year.

Earnings

CSPI

CSP Q1 EPS $0.05 Up From $(0.02) YoY, Sales $15.67M Up From $15.38M YoY

Shares of fast-food chain McDonald&#8217;s Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MCD#NYSE">MCD</a>) are trading higher in <a target="_blank" href="https://www.benzinga.com/premarket" rel="noreferrer noopener">premarket on Monday</a>.
The company reported a fourth-quarter sales decline of 0.3% year-on-year to $6.388 billion, missing the analyst consensus estimate of $6.442 billion.
Global comparable sales increased 0.4%, while U.S. comparable sales slipped 1.4%.
Comparable sales for International Operated Markets segment increased 0.1% and the International Developmental Licensed Markets segment improved 4.1%.
Systemwide sales increased&nbsp;2%&nbsp;(2%&nbsp;in constant currencies).
Sales by company-owned and operated restaurants dropped 7% to $2.3 billion, while sales from franchised restaurants grew 2% at $3.95 billion.
Systemwide sales to loyalty members across 60 loyalty markets were over $30 billion for the twelve-month period and approximately $8 billion for the quarter.
Also Read: <a target="_blank" href="https://www.benzinga.com/25/02/43570221/analysts-see-positive-momentum-for-expedia-on-strong-q4-earnings" rel="noreferrer noopener">Expedia&#8217;s Travel Momentum Grows, But Analysts Await Clearer Signs Of Long-Term Upside</a>
90-day active loyalty users were over 175 million across 60 loyalty markets as of year-end, with growth of about 15% Y/Y.
Total operating costs and expenses decreased 2% to $3.52 billion. Operating income for the quarter climbed 2% to $2.86 billion, with an operating margin of 44.9% compared to 43.7% last year.
Adjusted EPS of $2.83 was in line with the <a target="_blank" href="https://www.benzinga.com/earnings" rel="noreferrer noopener">analyst consensus estimate.</a>
The company held $1.08 billion in cash and equivalents as of December 31, 2024. Operating cash flow for twelve months totaled $9.44 billion with a free cash flow of $6.67 billion.
&#8220;Accelerating the Arches continues to be the right strategy as we focus on growing market share,&#8221; said CEO Chris Kempczinski.
&#8220;We&#8217;re playing to win, focusing on our customers with outstanding value, exciting menu innovation and culturally relevant marketing.&#8221;&nbsp;
Price Action: MCD shares are trading higher by 1.46% at $298.61 in premarket at the last check Monday.
Read Next:<a target="_blank" href="https://www.benzinga.com/25/02/43563232/software-company-solarwinds-to-go-private-in-44b-deal-stocks-skyrocket" rel="noreferrer noopener"></a>
<ul>
<li><a href="https://www.benzinga.com/25/02/43563232/software-company-solarwinds-to-go-private-in-44b-deal-stocks-skyrocket" target="_blank" rel="noreferrer noopener">Software Company SolarWinds Agrees To Go Private In $4.4B Deal</a></li>
</ul>
Image via Shutterstock.

Equities

Movers

McDonald's Q4 Earnings: Stagnant Revenue Growth, US Comp Sales Decline And More

Alexander's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALX#NYSE">ALX</a>) reported its Q4 earnings results on Monday, February 10, 2025 at 08:32 AM.
Here's what investors need to know about the announcement.
<h3>Earnings</h3>
Alexander's beat estimated earnings by 9.0%, reporting an EPS of $4.06 versus an estimate of $3.71.
Revenue was down $7.03 million from the same period last year.
<h3>Analysis of Past Earnings</h3>
During the previous quarter, the company beat on EPS by $0.27, leading to a 4.0% increase share price change the next day.

To track all earnings releases for Alexander's <a href="https://www.benzinga.com/quote/ALX/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Insights into Alexander's Q4 Earnings

Offerings

FTEL

Fitell Updated Registered Direct Offering For Up To $10.0M To Purchase Up To 1,195,220 Shares In The Form Of Warrants At $5.02/Share

Biotech

PALI

Palisade Bio Announces Preclinical Data Of PALI-2108 In Reducing Colitis Symptoms In DSS Mouse Model; Advancing To Phase 1a/b Study With Favorable Safety; Data Presented At 2025 Crohn's And Colitis Congress

WIIM

BDRX

Biodexa Pharmaceuticals shares are trading higher after the company announced it received FDA fast-track designation for eRapa.

Guggenheim analyst Yatin Suneja maintains Immunovant (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IMVT#NASDAQ">IMVT</a>) with a Buy and lowers the price target from $46 to $44.

Price Target

Analyst Ratings

IMVT

Guggenheim Maintains Buy on Immunovant, Lowers Price Target to $44

The <a href="https://womengrow.com/">Women Grow Leadership Summit 2025</a> is gearing up to be a defining moment for cannabis entrepreneurs, industry experts and advocates. Set against the backdrop of the Gaylord National Resort and Convention Center in National Harbor, Maryland, this two-day event (Feb. 17-18, 2025) promises a mix of high-profile speakers, networking opportunities and sector-specific workshops, all designed to ignite business growth and advocacy in cannabis.
<h3 class="wp-block-heading">A Summit Where Deals Happen</h3>
The Women Grow Leadership Summit 2025 is all about action. Designed to facilitate deal flow for license holders and emerging entrepreneurs, the event will feature matchmaking sessions, expert-led discussions and interactive tracks focused on business strategy, investment and policy.
Dr. Chanda Macias, CEO of Women Grow, emphasizes the movement behind the event. "The Women Grow Leadership Summit is more than just an event—it's a movement. Together, we will shape the future of cannabis and empower women across the globe."
<h3 class="wp-block-heading">Star-Studded Speaker Lineup</h3>
Some of the biggest names in sports, cannabis and business are headlining the summit. Brittney Griner, three-time Olympic gold medalist and six-time WNBA All-Star, will take the stage with a keynote titled "Cultivating Change: Empowering Women through Personal Leadership." The basketball star has been a fierce advocate for cannabis reform, speaking out about its role in healthcare and justice reform.
Also joining the conversation is Ricky Williams, the NFL icon turned cannabis entrepreneur who will host a fundraiser for cannabis access advocacy. Williams, known for his pioneering stance on cannabis use in professional sports, will discuss policy reform, athlete wellness and the road ahead for legalization.
<h3 class="wp-block-heading">Networking Meets Celebration</h3>
Beyond panel discussions, the summit fosters direct connections between industry leaders and aspiring entrepreneurs.
<ul>
<li>Day 1: Features a Careers in Cannabis job fair, expert-led panels and the Mardi Gras celebration, a high-energy networking event.</li>
<li>Day 2: Attendees can choose from curated tracks like Cooking with Cannabis and Business of Cannabis.</li>
</ul>
This year's event also takes place just minutes from Washington, D.C., making it an ideal platform for policy discussions with lawmakers and industry regulators.
<h3 class="wp-block-heading">Why Attend?</h3>
With major industry shifts and policy advancements on the horizon, Women Grow 2025 provides a front-row seat to the future of cannabis. The event offers:
<ul>
<li>High-level insights from top cannabis CEOs, investors, and policymakers.</li>
<li>Business matchmaking and networking with key players.</li>
<li>Workshops tailored to cannabis entrepreneurs at every level.</li>
<li>A chance to support advocacy initiatives for cannabis legalization and women's rights.</li>
</ul>
Whether you&#8217;re a seasoned operator, a first-time entrepreneur, or an industry advocate, this summit is designed to connect, inspire and empower.
<h2 class="wp-block-heading">Keynote Speakers</h2>
<h3 class="wp-block-heading">Brittney Griner</h3>
Three-time Olympic gold medalist and six-time WNBA All-Star.
<ul>
<li>Keynote: "Cultivating Change: Empowering Women through Personal Leadership"</li>
<li>Topics: Legalization, healthcare rights, gender equity.</li>
</ul>
<h3 class="wp-block-heading">Ricky Williams</h3>
NFL icon and founder of Project Champion.
<ul>
<li>Hosting a fundraiser to advocate for cannabis access and policy reform.</li>
<li>Topics: Cannabis in sports, wellness, and legalization advocacy.</li>
</ul>
<h2 class="wp-block-heading">Speakers</h2>
<h3 class="wp-block-heading">Dr. Chanda Macias</h3>
CEO, Women Grow
<h3 class="wp-block-heading">Gail Rand</h3>
CEO / Founder of Grand Consulting
<h3 class="wp-block-heading">Wanda James</h3>
CEO, Simply Pure
<h3 class="wp-block-heading">Maureen McNamara</h3>
Founder &amp; CEO, Cannabis Trainers
<h3 class="wp-block-heading">Jazmin Hupp</h3>
Former Co-Founder, Women Grow
<h3 class="wp-block-heading">Leah Heise</h3>
Partner at Wolf Meyer and Founder/CEO of Gemini Twin Consulting
<h3 class="wp-block-heading">Luna Stower</h3>
Chief Impact Officer, Ispire Vape Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISPR#NASDAQ">ISPR</a>)
<h3 class="wp-block-heading">Tai Duncan Atteberry</h3>
VP, Corporate Social Responsibility – Cresco Labs
<h3 class="wp-block-heading">Oludare Odumosu</h3>
Global MD/CEO, Zelira Therapeutics
<h3 class="wp-block-heading">Nicole Miller</h3>
Co-Owner Cultivation, Phyto Group LLC
…and many more.
Get your <a href="https://womengrow.com/tickets/">tickets</a> today.

Cannabis

Events

ISPR

Brittney Griner And Ricky Williams Headline Women Grow 2025 Leadership Summit, Key Event For Cannabis Industry

Guidance

VLCN

Volcon CFO Greg Endo Says "With The Cost Reductions We Have Made And The Anticipated Working Capital Requirements To Fund Inventory Purchases John Notes, We Expect To Be Cash Flow Positive On A Monthly Basis By Q4 Of 2025 And Will Be Able To Fund Operations Into 2026."

Barclays analyst Luke Sergott upgrades Waters (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WAT#NYSE">WAT</a>) from Underweight to Equal-Weight and raises the price target from $360 to $415.

Upgrades

Barclays Upgrades Waters to Equal-Weight, Raises Price Target to $415

Market Index Target Term Securities Linked To The Dow Jones Industrial Average

SunCar Technology Integrates DeepSeek Into Its Platform

Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) adoption is on track to <a href="https://www.benzinga.com/money/will-bitcoin-reach-1-million-a-coin">reach several billion users</a> by the end of the decade, according to Coinbase (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COIN#NASDAQ">COIN</a>) CEO Brian Armstrong.
In a <a href="https://x.com/brian_armstrong/status/1888822443873325247">statement</a> on X on Monday, Armstrong pointed to the rapid pace of Bitcoin growth, comparing it to the early adoption rates of mobile phones and the internet.
&#8220;Bitcoin adoption should get to several billion people by 2030 at current rates,&#8221; Armstrong wrote, emphasizing the acceleration in mainstream cryptocurrency use.
He was responding to a tweet by entrepreneur Mario Nawfal, who, citing data from BlackRock (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLK#NASDAQ">BLK</a>)stated that crypto adoption has grown 43% faster than mobile phones and 20% faster than the internet.
He said that the report suggests that younger generations, concerns over inflation, and a <a href="https://www.benzinga.com/etfs/specialty-etfs/25/02/43537016/donald-trump-once-said-bitcoin-was-based-on-thin-air-now-his-media-company-is-launching-btc-etf">pro-crypto stance</a> from U.S. leadership are key drivers of this expansion.
Meanwhile, <a href="https://www.benzinga.com/markets/cryptocurrency/25/02/43560433/bitcoin-to-hit-between-300000-and-1-5-million-by-2030-ark-invest#:~:text=The%20firm%20outlines%20several%20key,see%20a%20significant%20price%20boost.">institutional adoption</a> continues to grow, with Bitcoin ETFs projected to hit $250 billion in assets under management.
Regulatory clarity is also improving, further legitimizing Bitcoin as a mainstream financial asset.
&#8220;With Bitcoin ETFs projected to hit $250 billion and regulatory wins piling up, crypto's mainstream takeover is accelerating,&#8221; Nawfal said.
As Bitcoin adoption scales, experts see further integration into global finance, driven by both institutional participation and growing retail demand.
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/25/02/43589576/is-solanas-growth-being-held-back-by-a-technical-bottleneck">Is Solana&#8217;s Growth Being Held Back By A Technical Bottleneck?</a>
Why It Matters: Meanwhile, asset management giant BlackRock has increased its stake in Strategy Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTR#NASDAQ">MSTR</a>), a company best known for its <a href="https://www.benzinga.com/markets/cryptocurrency/25/02/43568126/blackrock-expands-investment-in-bitcoin-heavy-strategy-reaching-5-ownership">substantial Bitcoin holdings.</a>
A Feb. 6 filing with the U.S. Securities and Exchange Commission (SEC) shows BlackRock now owns approximately 11.26 million shares of Strategy, up from 9.48 million shares three months prior.
This brings BlackRock's total ownership in Strategy to 5%, reflecting an estimated $584 million investment based on Strategy's current share price of $325. 
In total, BlackRock&#8217;s stake is now valued at more than $3.67 billion. 
The company's growing exposure to Strategy aligns with the firm's ongoing accumulation of Bitcoin, which now stands at 471,107 BTC, worth over $46 billion at current prices.
BlackRock's increasing Bitcoin exposure marks a stark shift in the perspective of its CEO, Larry Fink, who once dismissed Bitcoin as an "index of money laundering" and doubted its legitimacy as a financial asset.
However, Fink's stance has significantly changed in recent years, particularly with BlackRock's launch of the iShares Bitcoin Trust (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IBIT#NASDAQ">IBIT</a>). 
He now refers to Bitcoin as a potential &#8220;international asset,&#8221; akin to gold, and sees Bitcoin ETFs as a means to offer <a href="https://www.benzinga.com/markets/cryptocurrency/25/01/42998035/bitcoin-adoption-still-early-blackrock-says">regulated access to digital assets. </a>
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/02/43570466/bitcoin-to-hit-all-time-highs-in-february-under-one-condition-standard-chartered-says">Bitcoin To Hit All-Time Highs In February Under One Condition, Standard Chartered Says</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

COIN

IBIT

MSTR

Coinbase CEO Brian Armstrong Says Bitcoin Adoption To Reach 'Billions' By 2030

Barclays analyst Luke Sergott upgrades Agilent Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/A#NYSE">A</a>) from Underweight to Equal-Weight and raises the price target from $135 to $145.

Barclays Upgrades Agilent Technologies to Equal-Weight, Raises Price Target to $145

Oncocyte Prices $29.1M Equity Offering At $2.05/Share

Edgewell Personal Care shares are trading lower after the company reported Q1 financial results and missed its adjusted EPS and revenue estimates.

First Quarter Fiscal 2025 Financial Highlights Compared to Prior Year
<ul>
<li>Sales revenue increased 6.1% to A$10.4 million due to strong demand for the Company's cold pressed canola oil. &nbsp;</li>
<li>Retail oil revenue increased 59.9% to A$5.7 million due to expanded distribution in leading retailers in Australia along with the addition of several new SKUs. &nbsp;</li>
<li>Net loss of A$0.6 million compared to net income of A$1.4 million, reflecting changes to sales mix along with the timing of planned investments in brand and marketing to support our GEO products. &nbsp;</li>
<li>Cash flow from operations improved to A$0.6 million compared to a use of A$1.5 million. &nbsp;</li>
</ul>

COOT

Australian Oilseeds Q1 2025 Revenue A$10.4M

ACHV

Achieve Life Sciences Announces Data Safety Monitoring Committee Did Not Identify Any Unexpected Treatment-Related Adverse Events In ORCA-OL Clinical Trial

Barclays analyst Luke Sergott downgrades Illumina (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ILMN#NASDAQ">ILMN</a>) from Equal-Weight to Underweight and lowers the price target from $130 to $100.

Downgrades

ILMN

Barclays Downgrades Illumina to Underweight, Lowers Price Target to $100

<a href="https://www.globenewswire.com/Tracker?data=8yL3Wa9ujlO_QaRuDxy5NlAAG1_xVgZGVCNyrgMsKnbefwkggeKiV95Cp9HQ36i_5TwcBbQIH_00gqdpQNB21P3j7Lgx2elgByHqB0fOKag=">Varonis Systems, Inc.</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRNS#NASDAQ">VRNS</a>), a leader in data security, announced that its board of directors authorized a share repurchase program allowing repurchases of up to $100.0 million of Varonis' common stock expected to be completed over the next 12 months.

Comments

Yubico

Yubico (YUBCF) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga